Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more

IPD Insider Trading (ImpediMed)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$21,065.28
Insider Selling (Last 12 Months): A$0.00

ImpediMed Insider Trading History Chart

This chart shows the insider buying and selling history at ImpediMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ImpediMed Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for IPD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more

ImpediMed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/7/2021Judith DownesInsiderBuy299,648A$0.04A$11,086.98
4/1/2021Amit PatelInsiderIssued200,893A$0.11A$22,098.23
1/4/2021Judith DownesInsiderIssued105,733A$0.13A$14,062.49
11/16/2020Richard CarreonInsiderIssued631,000A$0.10A$60,576.00
10/7/2020Robert (Bob) GrahamInsiderBuy269,684A$0.04A$9,978.31
7/1/2020Judith DownesInsiderIssued213,068A$0.07A$14,062.49
5/1/2020Robert (Bob) GrahamInsiderTransfer773,186A$0.04A$30,154.25
4/29/2020Judith DownesInsiderIssued143,175A$0.04A$5,583.83
1/2/2020Gary GoetzkeInsiderIssued137,195A$0.18A$24,009.13
7/24/2019Judith DownesInsiderIssued27,534A$0.11A$3,028.74
7/16/2019Richard CarreonInsiderExercise139,366A$0.11A$15,330.26
3/20/2019Amit PatelInsiderBuy88,000A$0.23A$19,800.00
3/13/2019Donald (Don) WilliamsInsiderBuy10,000A$0.24A$2,350.00
3/11/2019Scott WardInsiderBuy25,000A$0.24A$5,875.00
3/8/2019Donald (Don) WilliamsInsiderBuy10,000A$0.24A$2,400.00
3/6/2019Donald (Don) WilliamsInsiderBuy80,000A$0.25A$20,000.00
See Full Table
Insider Buying at ImpediMed?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ImpediMed and related companies.

SEC Filings (Institutional Ownership Changes) for ImpediMed (ASX:IPD)

ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
Read More on ImpediMed

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

1,616,138 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ImpediMed?

ImpediMed's top insider shareholders include:
  1. Amit Patel (Insider)
  2. Gary Goetzke (Insider)
  3. Judith Downes (Insider)
  4. Richard Carreon (Insider)
  5. Robert (Bob) Graham (Insider)
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more